You are here

  • Home
  • Archive
  • Volume 8, Issue 5
  • Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

Citation Tools

Article menu

Download PDFPDF

Commentary
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Belgodère L, Pougheon Bertrand D, Jaulent MC The Scientific Advisory Board of the ANSM, et al
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
BMJ Global Health 2023;8:e011966.